Академический Документы
Профессиональный Документы
Культура Документы
imaging equipment
23 December 2008
www.clearstate.com
India’s giant appetite for medical imaging
equipment Ivy Teh
India’s medical imaging sector is poised for a new accelerated phase of growth fuelled by
the availability of advanced technology and digital information. This market continues to be
one of the more progressive markets in Asia in terms of technology adoption. The
enhancements in technology have seen the growing adoption of new imaging technology
that combine high levels of accuracy with rapid, user friendly product formats. Along with
pressures to improve the quality of healthcare while keeping the medical treatments
affordable, new “greenfield” opportunities are emerging for suppliers to provide innovative
cost effective equipment.
India, with its huge population of over a billion people, offers itself as a country with huge
market potential even with a significant portion of the locals living below the international
poverty line. Currently, the public health sector is overburdened in the cities while those
living in the rural areas have minimal access to quality healthcare. Inefficiency has given
way to a booming private healthcare industry which now takes care of three quarters of the
nation’s needs. At the same time, rising income and health consciousness amongst the
urban Indian population are driving people to seek specialised care. The urban consuming
class is expected to grow from 78 million in 2001 to 250 million in 20101. India’s increasing
affluent middle class is demanding access to better healthcare; many Indians are now
choosing to purchase health insurance with either full or partial coverage, so more can
now afford to receive high quality treatment.
Another driver of demand for quality care comes from India’s lucrative medical tourism
business. Medical tourism in India is projected to grow by six times from US $350 million
now to a US $2 billion-industry in 20122. People from all over the world make their way to
India to seek world class medical treatment at a cost comparatively lower than at home.
Open-heart surgery that costs up to US$70,000 in Britain and US$150,000 in the US; only
costs between US$3,000 and US$10,000 in India’s top hospitals. Knee surgery costs
US$7,700 in India will cost US$16,950 in Britain. Dental, eye and cosmetic surgeries are
three to four times cheaper. These patients usually get an attractive deal that includes
flight, hotel accommodation, treatment and, often, a post-treatment vacation3.
Although, the urban Indians and medical tourist make up the minority in population terms,
they currently pay for about 75% of India’s medical treatment.
1
The Medical Device Market in India, Express Healthcare Management, 2006
2
Medical Tourism Corporation
3
Medical Tourism in India Indian Journal of Medical Ethics
www.clearstate.com
Opportunities in India’s public healthcare sector
Despite the unfavourable situation in the public health sector, the Indian government has
stated in its National Health Policy that it hopes to increase the number of healthcare
centres in remote areas and improve supply of essential healthcare services by boosting
the public healthcare expenditure to 2.0% of the gross domestic product (GDP) by 20104
providing a substantial potential market for the public sector as well as the likely resultant
greater collaborations between private sector and government. At present, this could
translate into opportunities for any suppliers that are innovative in providing low cost and
easy to use medical equipment for this untapped market segment.
The equipment poised for the greatest growth in India are those connected to its changing
disease profile. As more Indians lead sedentary lifestyles, smoke, and eat better, lifestyle
diseases such as cardiovascular disease and cancer are on the rise. Diagnostic devices
such as imaging, and surgical devices to treat these diseases are well-situated. Medical
imaging equipment constitutes approximately 30% of the total medical equipment market
in Indiai. Imaging technology include ultrasound scanners, magnetic resonance imaging
(MRIs), CT scanners (CTs), C-arms, colour dopplers, X-rays, and more recently 3D
imaging.
4
Economic Analysis for the Indian Healthcare Industry
5
The Medical Buyer, Oct 2008 issue
www.clearstate.com
major players in this market are Toshiba (Erbis), Blue Star (Hitachi), Trivitron (Neusoft),
and Shimadzu.
In 2006, mid-end scanners contributed toward 22% of the total market while high-end
scanners contributed toward 28% of the market. As most Indian consumers are not ready
for costly technology, low-end scanners continue to have a major market share. The
leaders in the mid-end segment in 2006 were Philips Medical and Siemens Medical while
GE Healthcare, Siemens Medical, and Philips Medical were the leaders in the high-end
segment.
High-end scanners being highly priced accounted for the highest sales value among the
three segments with an estimated value share of 53%. The mid-end and low-end
segments accounted for 25% and 22%, respectively6.
General x-ray market is expected to grow at a CAGR of 10% of higher. It is one of the
more exciting and competitive segments in imaging, where acquisition activities and new
product launches have been observed in the last year. GE Healthcare for instance,
launched HF Advantage, the next generation X-ray equipment, designed and developed in
India. The HF Advantage is considered an affordable high quality x-ray that offers
precision diagnostics at a lower radiation unlike conventional systems priced less.
Philips on the other hand, has undergone a flurry of acquisitions in 2008. They acquired
two Indian x-ray manufacturers; i) Alpha – a leading manufacturer of cardiovascular x-ray
systems and ii) Meditronics – a leading general x-ray systems manufacturer, in their
accelerating efforts to expand their healthcare business in India.
The current market for ultrasound equipment in India is approximately US$105 million and
is growing at a CAGR of approximately 20%. The Black & White (B&W) ultrasound market
is segmented into low and mid-end machines. The low-end B&W machines are mainly
portable units with limited applications. The B&W ultrasound market sells around 500 - 600
units sold a year in India, albeit at a low market value8.
6
The Medical Buyer, Nov 2007 issue
7
The Medical Buyer, Oct 2008 issue
8
The Medical Buyer, Oct 2008 issue
www.clearstate.com
The Color Dopplers ultrasound segment, on the other hand, has a lower unit volume sale
but represents over 70% of the market value. This segment can be categorized by low,
mid and high-end as well.
MRI: High-field 1.5 and 3.0 tesla MRIs replacing older 1.0 tesla drives market growth
The total market size for MRI is estimated to be around US$82 million in India in 20079.
MRI can be segmented into two categories, permanent magnet and super conducting
magnet. The super conducting segment represents the majority of installations with over
80% of the market value. Around 15% of the market size is occupied by the permanent
magnet segment while less than 5% is accounted for by refurbished equipment segment.
The MRI market can also be further segmented by magnetic field strength. The high-end
1.5 tesla and above segment is equally shared by Philips, GE and Siemens and has a
potential of approximately 18 - 20% of market size. There is also a rapidly growing
demand for the very high-field segment, the 3.0 tesla system, where installations have
been prominently seen in key facilities in the past 3 years. Siemens and Philips are market
leaders in the 3.0 tesla segment.
In the 1.0 Tesla segment, Siemens are market leaders closely followed by Philips and GE.
In the 0.5 Tesla segment competition mainly exists between Philips and GE. In the low
end Permanent Magnet system Hitachi poses tough competition for GE and Philips10.
9
Healthcare Management Technology, Feb1, 2008
10
Digital Technology in X-Rays, Express Pharma
www.clearstate.com
Problems Clearstate solves:
To subscribe to more Clearstate essays and to learn more about the firm, visit
the Clearstate website at www.clearstate.com
Ivy Teh is the Managing Director at Clearstate. She has advised international
medical device and equipment companies on market entry strategies,
acquisitions, R&D outsourcing, competitive benchmarking and marketing
strategies.
www.clearstate.com